Gyros AB appoints former APBiotech Marketing Director as Vice President

Gyros AB appoints former APBiotech Marketing Director as Vice President Gyros AB announced today the appointment of Camilla Huse Bondesson, as Vice President Marketing. Ms Huse Bondesson was formerly Marketing Director in Proteomics at APBiotech. Gyros AB announced today the appointment of Camilla Huse Bondesson as Vice President Marketing. Ms Huse Bondesson has held management positions in sales and marketing within biotechnology and diagnostics for over 18 years. Her two most recently held positions were as Marketing Director in Proteomics for Amersham Pharmacia Biotech and Product Manager in Drug Discovery for Biacore AB. "The experience that Ms Huse Bondesson brings with her to Gyros is invaluable. She will continue the build-up of our global marketing efforts in preparation for major product launches in 2002" said Per Sjöberg, Vice President Commercial Operations at Gyros AB in Uppsala, Sweden. Major pharmaceutical and diagnostic organizations have already expressed a high level of interest in the proprietary technology platform offered by Gyros. "I see my new role as a great challenge, not only to introduce a new product to the market place, but also to investigate and fully develop the enormous potential of this exciting new platform", says Ms Huse Bondesson. About Gyros AB Gyros AB offers the pharmaceutical, biotechnology and diagnostic companies access to a unique, proprietary technology platform in which routine or non-routine laboratory processes can be miniaturized and integrated into client-specific CDs. Hundreds of samples can be processed in parallel on these disposable microlaboratories. This new platform brings outstanding gains in efficiency, cost-effectiveness and information content. The ability to integrate different laboratory steps on a single CD offers the potential to reassess and redesign traditional working procedures. The company was founded in 2000 and has its offices based in the Science Park in Uppsala, Sweden. For further information, visit www.gyrosmicro.com or contact: Maris Hartmanis, President and CEO, Gyros AB Tel: +46 (0)18 566 330 Mobile: +46 (0)70 562 8617 Email: maris.hartmanis@gyrosmicro.com Per Sjöberg, Vice President Commercial Operations, Gyros AB Tel: +46 (0)18 566 318 Mobile: +46 (0)70 5444799 Email: per.sjoberg@gyrosmicro.com Media information (financial) Maris Hartmanis, President and CEO, Gyros AB Tel: +46 (0)18 566 330 Mobile: +46 (0)70 562 8617 Email: maris.hartmanis@gyrosmicro.com Media information (trade): Sue Cresswell, Marketing Communications Tel: +46 (0)8 54472620 Mobile: +46 (0)705 519520 Email: sue.cresswell@gyrosmicro.com Statements in this press release that are not strictly historical may be forward-looking and include risks and uncertainties. Therefore, though based on Gyros' current expectations, it should be duly noted that a variety of factors could cause actual results and experiences to differ materially from what is herein expressed. Risks and uncertainties include, but are not limited to, risks associated with the management of growth and international operations (including effects of currency fluctuations), variability of operating results, unforeseen changes in the diagnostic and pharmaceutical markets, market competition, rapid or unexpected changes in technologies, fluctuations in product demand, difficulties to successfully develop, adapt, produce or commercialize products, the ability to identify and develop new products and to differentiate products from those of competitors, as well as various legal hazards. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.bit.se/bitonline/2001/06/14/20010611BIT00800/bit0001.doc http://www.bit.se/bitonline/2001/06/14/20010611BIT00800/bit0001.pdf

About Us

Gyros miniaturizes and integrates laboratory processes into application-specific Gyrolab? microlaboratories that process hundreds of samples in parallel at nanoliter scale. Scientists generate more information from less sample, improve lab performance and increase productivity.

Subscribe